CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (AMEX: CSLLY) | Delayed: 32.41 +0.20 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.21 | 52 Week High | $45.60 | |||
| Open | $32.07 | 52 Week Low | $33.39 | |||
| Day High | $32.41 | P/E | N/A | |||
| Day Low | $32.07 | EPS | $0.00 | |||
| Volume | 1,818 | |||||
